300244.SZ · 迪安诊断
China A-shares · RS rating 93 · As of 2026-10-14
| Price | 19.68 CNY |
|---|---|
| 1-day change | -4.3% |
| RS rating (overall / 1M / 3M / 12M) | 93 / 93 / 68 / 85 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 45 / 48 / 35 |
| Industry group (rank) | Medical-Research Eqp/Svc (6) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +12.4% |
| Distance from 52-week high | +33.3% |
| Market cap (USD) | $1.9B |